Yamanaka, N. & Shimizu, A. Role of glomerular endothelial damage in progressive renal disease. Kidney Blood Press. Res 22(1–2), 13–20 (1999).
Karaiskos, N. et al. A single-cell transcriptome atlas of the mouse glomerulus. J. Am. Soc. Nephrol. 29(8), 2060–2068 (2018).
Fu, J. et al. Single-cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease. J Am Soc Nephrol 30(4), 533–545 (2019).
Brunskill, E. W. & Potter, S. S. Gene expression programs of mouse endothelial cells in kidney development and disease. PLoS ONE 5(8), e12034 (2010).
Fu, J. et al. Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice. Kidney Int. 94(2), 326–345 (2018).
Dumas, S. J. et al. Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation. J. Am. Soc. Nephrol. 31(1), 118–138 (2020).
Sedrakyan, S. et al. Amniotic fluid stem cell-derived vesicles protect from VEGF-induced endothelial damage. Sci. Rep. 7(1), 16875 (2017).
Voyta, J. C. et al. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99(6), 2034–2040 (1984).
Pautz, A. et al. Cross-talk between nitric oxide and superoxide determines ceramide formation and apoptosis in glomerular cells. Kidney Int. 61(3), 790–796 (2002).
Sekine, A. et al. Prominin-1/CD133 expression as potential tissue-resident vascular endothelial progenitor cells in the pulmonary circulation. Am. J. Physiol. Lung Cell Mol. Physiol. 310(11), L1130–L1142 (2016).
Valle, I. et al. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc. Res. 66(3), 562–573 (2005).
Leone, T. C. & Kelly, D. P. Transcriptional control of cardiac fuel metabolism and mitochondrial function. Cold Spring Harb. Symp. Quant. Biol. 76, 175–182 (2011).
Liang, H. & Ward, W. F. PGC-1alpha: a key regulator of energy metabolism. Adv. Physiol. Educ. 30(4), 145–151 (2006).
Christensen, P. M. et al. Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1. FASEB J. 30(6), 2351–2359 (2016).
Ren, K. et al. Apolipoprotein M. Clin. Chim. Acta 15(446), 21–29 (2015).
Tsukahara, R. et al. Heart-type fatty-acid-binding protein (FABP3) is a lysophosphatidic acid-binding protein in human coronary artery endothelial cells. FEBS Open Bio 31(4), 947–951 (2014).
Wu, W. et al. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. Drug Metab. Dispos. 41(10), 1825–1834 (2013).
Vallon, V. et al. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am. J. Physiol. Renal Physiol. 302(10), F1293–F1299 (2012).
Sedrakyan, S. et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J. Am. Soc. Nephrol. 23(4), 661–673 (2012).
Vlahu, C. A. et al. Damage of the endothelial glycocalyx in dialysis patients. J. Am. Soc. Nephrol. 23(11), 1900–1908 (2012).
Padberg, J. S. et al. Damage of the endothelial glycocalyx in chronic kidney disease. Atherosclerosis 234(2), 335–343 (2014).
Williams, K. J. et al. Decorin deficiency enhances progressive nephropathy in diabetic mice. Am. J. Pathol. 171(5), 1441–1450 (2007).
Pozzi, A. & Zent, R. Integrins in kidney disease. J. Am. Soc. Nephrol. 24(7), 1034–1039 (2013).
Mathew, S. et al. Integrins in renal development. Pediatr. Nephrol. 27(6), 891–900 (2012).
Kreidberg, J. A. & Symons, J. M. Integrins in kidney development, function, and disease. Am. J. Physiol. Renal Physiol. 279(2), F233–F242 (2000).
Lelongt, B. & Ronco, P. Role of extracellular matrix in kidney development and repair. Pediatr. Nephrol. 18(8), 731–742 (2003).
Müller, U. & Brändli, A. W. Cell adhesion molecules and extracellular-matrix constituents in kidney development and disease. J. Cell Sci. 112(Pt 22), 3855–3867 (1999).
Bülow, R. D. & Boor, P. Extracellular matrix in kidney fibrosis: more than just a scaffold. J. Histochem. Cytochem. 22, 22155419849388 (2019).
Sato-Nishiuchi, R. et al. Polydom/SVEP1 is a ligand for integrin α9β1. J Biol Chem 287(30), 25615–25630 (2012).
Kelly-Goss, M. R. et al. Dynamic, heterogeneous endothelial Tie2 expression and capillary blood flow during microvascular remodeling. Sci. Rep. 7(1), 9049 (2017).
Adamcic, U., Yurkiewich, A. & Coomber, B. L. Differential expression of Tie2 receptor and VEGFR2 by endothelial clones derived from isolated bovine mononuclear cells. PLoS ONE 7(12), e53385 (2012).
Barry, D.M., McMillan, E.A., Kunar, B., et al. Molecular determinants of nephron vascular specialization in the kidney. Nat. Commun. 10(1), 5705 (2019)
Fathers, K. E. et al. Heterogeneity of Tie2 expression in tumor microcirculation influence of cancer type, implantation site, and response to therapy. Am. J. Pathol. 167(6), 1753–1762 (2005).
Bapst, A.M., Dahl, S.L., Knöpfel, T., Wenger, R.H. Cre-mediated, loxP independent sequential recombination of a tripartite transcriptional stop cassette allows for partial read-through transcription. Biochim. Biophys. Acta Gene. Regul. Mech. 1863(8), 194568 (2020)
Ostrowski, S. R. et al. Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: an observational study. J. Crit. Care 30(1), 90–96 (2015).
Schmidt, E. P. et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat. Med. 18(8), 1217–1223 (2012).
Garsen, M. et al. Heparanase is essential for the development of acute experimental glomerulonephritis. Am. J. Pathol. 186(4), 805–815 (2016).
Lygizos, M. I. et al. Heparanase mediates renal dysfunction during early sepsis in mice. Physiol. Rep. 1(6), e00153 (2013).
Schmidt, E. P. et al. Urinary glycosaminoglycans predict outcomes in septic shock and acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 194(4), 439–449 (2016).
Sun, X. et al. Analysis of total human urinary glycosaminoglycan disaccharides by liquid chromatography-tandem mass spectrometry. Anal. Chem. 87(12), 6220–6227 (2015).
Witjas, F. M. R. et al. Concise review: the endothelial cell extracellular matrix regulates tissue homeostasis and repair. Stem Cells Transl. Med. 8(4), 375–382 (2019).
Munger, J. S. et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96(3), 319–328 (1999).
Annes, J. P., Rifkin, D. B. & Munger, J. S. The integrin alphaVbeta6 binds and activates latent TGFbeta3. FEBS Lett. 511(1–3), 65–68 (2002).
Hahm, K. et al. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Am J Pathol. 170(1), 110–125 (2007).
Erikson, D. W. et al. Secreted phosphoprotein 1 (SPP1, osteopontin) binds to integrin alpha v beta 6 on porcine trophectoderm cells and integrin alpha v beta 3 on uterine luminal epithelial cells, and promotes trophectoderm cell adhesion and migration. Biol. Reprod. 81(5), 814–825 (2009).
Taooka, Y. et al. The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J. Cell Biol. 145(2), 413–420 (1999).
Sato-Nishiuchi, R. et al. Polydom/SVEP1 is a ligand for integrin α9β1. J. Biol. Chem 287(30), 25615–25630 (2012).
Karpanen, T. et al. An evolutionarily conserved role for polydom/Svep1 during lymphatic vessel formation. Circ. Res. 120(8), 1263–1275 (2017).
Morooka, N. et al. Polydom is an extracellular matrix protein involved in lymphatic vessel remodeling. Circ. Res. 120(8), 1276–1288 (2017).
Rohlenova, K. et al. Endothelial cell metabolism in health and disease. Trends Cell Biol. 28(3), 224–236 (2018).
Wei, P. Z. & Szeto, C. C. Mitochondrial dysfunction in diabetic kidney disease. Clin. Chim. Acta 496, 108–116 (2019).
Makó, V. et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1β, TNF-α, and LPS. Cytometry A. 77(10), 962–970 (2010).
Mai, J. et al. An evolving new paradigm: endothelial cells–conditional innate immune cells. J. Hematol. Oncol. 6, 61 (2013).
O’Carroll, S. J. et al. Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells. Neuroinflammation 12, 131 (2015).
Dimou, P. et al. The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis. Sci. Rep. 9(1), 8348 (2019).
Guo, C. et al. Apelin promotes diabetic nephropathy by inducing podocyte dysfunction via inhibiting proteasome activities. J. Cell Mol. Med. 19(9), 2273–2285 (2015).
Yamamoto, T. et al. Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle. Biochim. Biophys. Acta 1810(9), 853–862 (2011).
Hwangbo, C. et al. Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin’s glucose-lowering effects. Sci. Transl. Med. 9(407), eaad 4000 (2017).
El-Shehaby, A. M. et al. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients. Scand. J. Clin. Lab. Invest. 70(6), 421–427 (2010).
Bo, Y. & Yuan, L. P. Glomerular expression of apelin and its association with proteinuria. Indian J. Pediatr. 79(8), 1028–1032 (2012).
Chen, H. et al. Apelin protects against acute renal injury by inhibiting TGF-β1. Biochim. Biophys. Acta 1852(7), 1278–1287 (2015).
Małyszko, J. et al. Apelin and cardiac function in hemodialyzed patients: possible relations?. Am. J .Nephrol. 26(2), 121–126 (2006).
Lu, Y. et al. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids 43(5), 2125–2136 (2012).
Dean, R. A. et al. Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 112(8), 3455–3464 (2008).
Rao, V. H. et al. Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome. Am. J. Pathol. 169(1), 32–46 (2006).
Abraham, A. P. et al. Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis. Nephrology (Carlton) 23(2), 183–189 (2018).
Liu, Y. Cellular and molecular mechanisms of renal fibrosis. Nat. Rev. Nephrol. 7(12), 684–696 (2011).
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9(7), 676–682 (2012).
Kang, J. J. et al. Quantitative imaging of basic functions in renal (patho)physiology. Am. J. Physiol. Renal Physiol. 291(2), F495-502 (2006).
Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res 47(D1), D766–D773 (2019).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1), 15–21 (2013).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1), 139–140 (2010).
Falcon, S. & Gentleman, R. Using GOstats to test gene lists for GO term association. Bioinformatics 23(2), 257–258 (2007).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498–2504 (2003).
Ono, K. et al. CyREST: Turbocharging Cytoscape Access for External Tools via a RESTful API. F1000Res. 5(4), 478 (2015).